1	LONDON	london	NNP	_	3	nn	_
2	(	(	-LRB-	_	3	punct	_
3	Reuters	reuters	NNP	_	11	nsubj	11:A0=PAG
4	)	)	-RRB-	_	3	punct	_
5	-	-	:	p2=.	3	punct	_
6	Britain	britain	NNP	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	AstraZeneca	astrazeneca	NNP	_	3	appos	_
9	on	on	IN	_	8	prep	_
10	Monday	monday	NNP	_	9	pobj	_
11	rejected	reject	VBD	pb=reject.01	0	root	_
12	a	a	DT	_	18	det	_
13	sweetened	sweeten	VBN	p2=JJ|pb=sweeten.02	18	amod	_
14	and	and	CC	_	13	cc	_
15	"	"	``	_	18	punct	_
16	final	final	JJ	_	18	amod	_
17	"	"	''	_	18	punct	_
18	offer	offer	NN	p2=VBP	11	dobj	11:A1=PPT;13:A1=PPT
19	from	from	IN	_	18	prep	_
20	Pfizer	pfizer	NNP	_	19	pobj	_
21	,	,	,	_	11	punct	_
22	puncturing	puncture	VBG	pb=puncture.01	11	advcl	11:AM-PRD
23	the	the	DT	_	25	det	_
24	U.S.	u.s.	NNP	_	25	nn	_
25	drugmaker	drugmaker	NN	p2=NNP	27	poss	_
26	's	's	POS	_	25	possessive	_
27	plan	plan	NN	_	22	dobj	22:A1=PPT
28	for	for	IN	_	27	prep	_
29	a	a	DT	_	30	det	_
30	merger	merger	NN	_	28	pobj	_
31	to	to	TO	_	32	aux	_
32	create	create	VB	pb=create.01	30	infmod	_
33	the	the	DT	_	34	det	_
34	world	world	NN	_	38	poss	_
35	's	's	POS	_	34	possessive	_
36	biggest	big	JJS	_	38	amod	_
37	pharmaceuticals	pharmaceutical	NNS	_	38	nn	_
38	group	group	NN	_	32	dobj	32:A1=PPT
39	.	.	.	_	11	punct	_

1	The	the	DT	_	2	det	_
2	rebuff	rebuff	NN	_	3	nsubj	3:A1=PPT
3	came	come	VBD	pb=come.01	0	root	_
4	nine	#crd#	CD	_	5	num	_
5	hours	hour	NNS	_	3	npadvmod	_
6	after	after	IN	p2=RBR	8	mark	_
7	Pfizer	pfizer	NNP	p2=NN	8	nsubj	8:A0
8	said	say	VBD	pb=say.01	3	advcl	3:AM-TMP
9	on	on	IN	_	8	prep	8:AM-TMP
10	Sunday	sunday	NNP	_	11	nn	_
11	night	night	NN	_	9	pobj	_
12	it	it	PRP	_	14	nsubj	14:A0=PAG
13	had	have	VBD	_	14	aux	_
14	raised	raise	VBN	pb=raise.01	8	ccomp	8:A1=PPT
15	its	its	PRP$	_	17	poss	_
16	takeover	takeover	NN	_	17	nn	_
17	offer	offer	NN	p2=VB	14	dobj	14:A1=PPT
18	to	to	IN	_	14	prep	14:A4=GOL
19	55	0	CD	_	20	num	_
20	pounds	pound	NNS	_	18	pobj	_
21	a	a	DT	_	22	det	_
22	share	share	NN	_	20	npadvmod	_
23	,	,	,	_	20	punct	_
24	or	or	CC	_	20	cc	_
25	around	around	IN	p2=RB	27	advmod	_
26	70	0	CD	_	27	number	_
27	billion	#crd#	CD	_	28	num	_
28	pounds	pound	NNS	_	20	conj	_
29	in	in	IN	_	14	prep	_
30	total	total	NN	_	29	pobj	_
31	,	,	,	_	3	punct	_
32	and	and	CC	_	3	cc	_
33	would	would	MD	_	34	aux	34:AM-MOD
34	walk	walk	VB	pb=walk.01	3	conj	_
35	away	away	RB	_	34	advmod	34:AM-DIR
36	if	if	IN	_	40	mark	_
37	AstraZeneca	astrazeneca	NNP	_	40	nsubj	40:A0=PAG
38	did	do	VBD	_	40	aux	_
39	not	not	RB	_	40	neg	40:AM-NEG
40	accept	accept	VB	pb=accept.01	34	advcl	34:AM-ADV
41	it	it	PRP	_	40	dobj	40:A1=PPT
42	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	rejection	rejection	NN	_	3	nsubj	3:A0=PAG;7:A0=PPT;12:A0=PAG
3	left	leave	VBD	pb=leave.02	0	root	_
4	some	some	DT	_	6	det	_
5	major	major	JJ	_	6	amod	_
6	shareholders	shareholder	NNS	_	3	dobj	3:A1=PPT
7	fuming	fume	VBG	pb=fume.01	3	xcomp	3:A2=GOL
8	as	as	IN	_	7	prep	7:A1=CAU
9	shares	share	NNS	_	8	pobj	_
10	in	in	IN	_	9	prep	_
11	AstraZeneca	astrazeneca	NNP	_	10	pobj	_
12	slumped	slump	VBD	pb=slump.01	3	conj	_
13	11	0	CD	_	14	num	_
14	percent	percent	NN	_	16	nsubj	16:A1=PPT
15	to	to	TO	_	16	aux	_
16	close	close	VB	pb=close.02	12	advcl	12:A4=GOL
17	at	at	IN	_	16	prep	16:AM-EXT
18	42.88	0	CD	_	19	num	_
19	pounds	pound	NNS	_	17	pobj	_
20	after	after	IN	p2=RB	16	prep	16:AM-TMP
21	falling	fall	VBG	pb=fall.01	20	pcomp	_
22	as	as	RB	_	25	advmod	_
23	much	much	JJ	p2=RB	25	amod	_
24	as	as	IN	_	25	quantmod	_
25	15	0	CD	_	26	num	_
26	percent	percent	NN	_	21	npadvmod	21:A2=EXT
27	-	-	:	p2=HYPH	16	punct	_
28	their	their	PRP$	_	32	poss	_
29	biggest	big	JJS	_	32	amod	_
30	ever	ever	RB	_	31	advmod	_
31	intra-day	intra-day	JJ	p2=HYPH	32	amod	_
32	decline	decline	NN	_	26	appos	_
33	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A1
2	rose	rise	VBD	pb=rise.01	0	root	_
3	1	0	CD	_	4	num	_
4	percent	percent	NN	_	2	npadvmod	2:A2=EXT
5	in	in	IN	_	2	prep	2:AM-LOC
6	New	new	NNP	_	7	nn	_
7	York	york	NNP	_	5	pobj	_
8	.	.	.	_	2	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NN	2	nn	_
2	Chairman	chairman	NNP	_	4	nn	_
3	Leif	leif	NNP	_	4	nn	_
4	Johansson	johansson	NNP	_	5	nsubj	5:A0=PAG
5	told	tell	VBD	pb=tell.01	0	root	_
6	Reuters	reuters	NNP	p2=NNS	5	dobj	5:A2=GOL
7	he	he	PRP	_	9	nsubj	9:A0
8	now	now	RB	_	9	advmod	9:AM-TMP
9	saw	see	VBD	p2=VBZ|pb=see.01	5	ccomp	5:A1=PPT
10	no	no	DT	_	11	det	_
11	prospect	prospect	NN	_	9	dobj	9:A1
12	of	of	IN	_	11	prep	_
13	a	a	DT	_	14	det	_
14	deal	deal	NN	_	12	pobj	_
15	with	with	IN	_	14	prep	_
16	Pfizer	pfizer	NNP	p2=NN	15	pobj	_
17	before	before	IN	_	9	prep	9:AM-TMP
18	a	a	DT	_	19	det	_
19	deadline	deadline	NN	_	17	pobj	23:A1=PPT
20	of	of	IN	_	19	prep	_
21	May	may	NNP	_	20	pobj	_
22	26	0	CD	_	21	num	_
23	set	set	VBN	p2=NN|pb=set.01	19	partmod	_
24	under	under	IN	_	23	prep	23:A2=LOC
25	British	british	JJ	_	27	amod	_
26	takeover	takeover	NN	_	27	nn	_
27	rules	rule	NNS	_	24	pobj	_
28	,	,	,	_	27	punct	_
29	or	or	CC	_	27	cc	_
30	any	any	DT	_	31	det	_
31	likelihood	likelihood	NN	_	27	conj	_
32	of	of	IN	_	31	prep	_
33	that	that	DT	_	34	det	_
34	deadline	deadline	NN	_	32	pobj	36:A1=PPT
35	being	be	VBG	_	36	auxpass	_
36	extended	extend	VBN	p2=JJ|pb=extend.01	34	partmod	_
37	.	.	.	_	5	punct	_

1	Experts	expert	NNS	_	3	nsubj	3:A0
2	also	also	RB	_	3	advmod	3:AM-DIS
3	said	say	VBD	pb=say.01	0	root	_
4	Pfizer	pfizer	NNP	_	6	nsubj	6:A0
5	had	have	VBD	_	6	aux	_
6	left	leave	VBN	pb=leave.01	3	ccomp	3:A1=PPT
7	itself	itself	PRP	_	6	dobj	_
8	no	no	DT	_	9	det	_
9	room	room	NN	_	6	dobj	6:A1=DIR
10	to	to	TO	_	11	aux	_
11	return	return	VB	pb=return.01	9	infmod	_
12	with	with	IN	_	11	prep	11:AM-MNR
13	a	a	DT	_	18	det	_
14	last	last	JJ	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	minute	minute	NN	_	18	nn	_
17	higher	high	JJR	p2=NN	18	amod	_
18	offer	offer	NN	p2=VBP	12	pobj	_
19	due	due	IN	p2=JJ	18	prep	_
20	to	to	IN	_	19	pcomp	_
21	the	the	DT	_	24	det	_
22	strict	strict	JJ	_	24	amod	_
23	takeover	takeover	NN	_	24	nn	_
24	code	code	NN	_	19	pobj	_
25	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	world	world	NN	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	drugs	drug	NNS	_	10	nn	_
10	firm	firm	NN	p2=JJ	4	dobj	4:A1=PPT
11	,	,	,	_	4	punct	_
12	with	with	IN	_	4	prep	_
13	a	a	DT	_	14	det	_
14	headquarters	headquarters	NN	_	12	pobj	_
15	in	in	IN	_	14	prep	_
16	New	new	NNP	_	17	nn	_
17	York	york	NNP	_	15	pobj	_
18	but	but	CC	p2=IN	14	cc	_
19	a	a	DT	_	21	det	_
20	tax	tax	NN	_	21	nn	_
21	base	base	NN	_	14	conj	_
22	in	in	IN	_	21	prep	_
23	Britain	britain	NNP	_	22	pobj	29:AM-LOC
24	,	,	,	_	23	punct	_
25	where	where	WRB	_	29	advmod	29:R-AM-LOC
26	corporate	corporate	JJ	_	28	amod	_
27	tax	tax	NN	_	28	nn	_
28	rates	rate	NNS	_	29	nsubj	29:A1=PPT
29	are	be	VBP	pb=be.01	23	rcmod	_
30	lower	low	JJR	_	29	acomp	29:A2=PRD
31	than	than	IN	_	30	prep	_
32	in	in	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	United	united	NNP	_	35	nn	_
35	States	states	NNP	_	32	pobj	_
36	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	plan	plan	NN	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	met	meet	VBN	pb=meet.01	0	root	_
5	entrenched	entrenched	JJ	p2=VBN	6	amod	_
6	opposition	opposition	NN	_	4	dobj	4:A1=PPT
7	from	from	IN	_	6	prep	_
8	AstraZeneca	astrazeneca	NNP	_	7	pobj	_
9	,	,	,	_	6	punct	_
10	as	as	RB	_	12	advmod	_
11	well	well	RB	_	12	advmod	_
12	as	as	IN	_	6	cc	_
13	politicians	politician	NNS	_	6	conj	_
14	and	and	CC	_	13	cc	_
15	scientists	scientist	NNS	_	13	conj	17:A0=PPT
16	who	who	WP	p2=VBP	17	nsubj	17:R-A0
17	fear	fear	VBP	pb=fear.01	15	rcmod	_
18	cuts	cut	NNS	_	17	dobj	17:A1=PAG
19	to	to	IN	_	17	prep	_
20	jobs	job	NNS	_	19	pobj	_
21	and	and	CC	_	20	cc	_
22	research	research	NN	_	20	conj	_
23	.	.	.	_	4	punct	_

1	"	"	``	_	3	punct	_
2	It	it	PRP	_	3	nsubj	3:A1=PPT
3	died	die	VBD	pb=die.01	0	root	_
4	of	of	IN	_	3	prep	3:AM-CAU
5	multiple	multiple	JJ	_	6	amod	_
6	wounds	wound	NNS	_	4	pobj	_
7	.	.	.	_	3	punct	_

1	Too	too	RB	p2=JJ	2	advmod	_
2	little	little	JJ	_	3	amod	_
3	cash	cash	NN	_	0	root	_
4	,	,	,	_	3	punct	_
5	too	too	RB	_	6	advmod	_
6	many	many	JJ	_	7	amod	_
7	suspicions	suspicion	NNS	_	3	appos	_
8	about	about	IN	_	7	prep	_
9	Pfizer	pfizer	NNP	_	11	poss	_
10	's	's	POS	_	9	possessive	_
11	motives	motive	NNS	_	8	pobj	_
12	,	,	,	_	3	punct	_
13	and	and	CC	_	3	cc	_
14	too	too	RB	_	15	advmod	_
15	little	little	JJ	_	16	amod	_
16	confidence	confidence	NN	_	3	conj	_
17	in	in	IN	_	16	prep	_
18	its	its	PRP$	_	19	poss	_
19	assurances	assurance	NNS	_	17	pobj	_
20	about	about	IN	_	19	prep	_
21	jobs	job	NNS	_	20	pobj	_
22	,	,	,	_	24	punct	_
23	"	"	''	_	24	punct	_
24	said	say	VBD	pb=say.01	0	root	_
25	Erik	erik	NNP	_	26	nn	_
26	Gordon	gordon	NNP	_	24	nsubj	24:A0
27	,	,	,	_	26	punct	_
28	professor	professor	NN	_	26	appos	_
29	at	at	IN	_	28	prep	_
30	the	the	DT	_	31	det	_
31	University	university	NNP	_	36	poss	_
32	of	of	IN	_	31	prep	_
33	Michigan	michigan	NNP	_	32	pobj	_
34	's	's	POS	_	31	possessive	_
35	Ross	ross	NNP	_	36	nn	_
36	School	school	NNP	_	29	pobj	_
37	of	of	IN	_	36	prep	_
38	Business	business	NNP	_	37	pobj	_
39	.	.	.	_	24	punct	_

1	"	"	``	_	6	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	chances	chance	NNS	_	6	nsubj	_
5	are	be	VBP	_	6	aux	_
6	going	go	VBG	pb=go.01	0	root	_
7	down	down	RB	_	6	advmod	6:AM-DIR
8	,	,	,	_	6	punct	_
9	despite	despite	IN	_	6	prep	6:AM-ADV
10	its	its	PRP$	_	11	poss	_
11	offer	offer	NN	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	a	a	DT	_	15	det	_
14	higher	high	JJR	_	15	amod	_
15	price	price	NN	_	12	pobj	_
16	.	.	.	_	6	punct	_
17	"	"	''	_	6	punct	_

1	Johansson	johansson	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	he	he	PRP	_	5	nsubj	5:A0=PAG
4	had	have	VBD	_	5	aux	_
5	made	make	VBN	pb=make.02	2	ccomp	2:A1=PPT
6	clear	clear	JJ	_	5	oprd	5:A1=PRD
7	in	in	IN	_	5	prep	5:AM-LOC
8	discussions	discussion	NNS	_	7	pobj	_
9	with	with	IN	_	8	prep	_
10	Pfizer	pfizer	NNP	_	9	pobj	_
11	that	that	IN	_	16	complm	_
12	his	his	PRP$	_	13	poss	_
13	board	board	NN	_	16	nsubj	16:A0=PAG
14	could	could	MD	_	16	aux	16:AM-MOD
15	only	only	RB	_	16	advmod	16:AM-ADV
16	recommend	recommend	VB	pb=recommend.01	5	ccomp	_
17	a	a	DT	_	18	det	_
18	bid	bid	NN	_	16	dobj	16:A1=PPT;20:A1=PPT
19	that	that	WDT	_	20	nsubj	20:R-A1
20	was	be	VBD	pb=be.01	18	rcmod	_
21	more	more	JJR	_	23	amod	_
22	than	than	IN	_	23	quantmod	_
23	10	0	CD	_	24	num	_
24	percent	percent	NN	_	25	npadvmod	_
25	above	above	IN	_	20	prep	20:A2=PRD
26	an	an	DT	_	27	det	_
27	offer	offer	NN	_	25	pobj	39:A1
28	of	of	IN	_	27	prep	_
29	53.50	0	CD	_	30	num	_
30	pounds	pound	NNS	_	28	pobj	31:A1
31	made	make	VBN	pb=make.LV	30	partmod	_
32	by	by	IN	_	31	agent	31:A0
33	Pfizer	pfizer	NNP	_	32	pobj	_
34	on	on	IN	_	27	prep	_
35	Friday	friday	NNP	_	34	pobj	_
36	,	,	,	_	27	punct	_
37	which	which	WDT	_	39	nsubj	39:R-A1
38	would	would	MD	_	39	aux	39:AM-MOD
39	amount	amount	VB	pb=amount.01	27	rcmod	_
40	to	to	IN	_	39	prep	39:A2=PRD
41	at	at	IN	p2=RB	42	advmod	_
42	least	least	JJS	_	43	advmod	_
43	58.85	0	CD	_	44	num	_
44	pounds	pound	NNS	_	40	pobj	_
45	.	.	.	_	2	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG;5:A0=PAG
2	blamed	blame	VBD	pb=blame.01	0	root	_
3	Pfizer	pfizer	NNP	_	2	dobj	2:A1=PPT
4	for	for	IN	_	2	prep	2:A2=PRD
5	calling	call	VBG	pb=call.03	4	pcomp	_
6	a	a	DT	_	7	det	_
7	halt	halt	NN	_	5	dobj	5:A1=PPT
8	to	to	IN	_	5	prep	5:A2=GOL
9	discussions	discussion	NNS	_	8	pobj	_
10	after	after	IN	_	9	prep	_
11	a	a	DT	_	13	det	_
12	telephone	telephone	NN	_	13	nn	_
13	call	call	NN	_	10	pobj	14:A1=PPT
14	lasting	last	VBG	pb=last.01	13	partmod	_
15	more	more	JJR	p2=RBR	14	dobj	_
16	than	than	IN	_	15	prep	_
17	an	an	DT	_	18	det	_
18	hour	hour	NN	_	16	pobj	_
19	with	with	IN	_	14	prep	14:A2=VSP
20	Pfizer	pfizer	NNP	_	22	poss	_
21	's	's	POS	_	20	possessive	_
22	chairman	chairman	NN	_	19	pobj	_
23	and	and	CC	_	22	cc	_
24	CEO	ceo	NNP	p2=NN	26	nn	_
25	Ian	ian	NNP	_	26	nn	_
26	Read	read	NNP	_	22	conj	_
27	on	on	IN	_	26	prep	_
28	Sunday	sunday	NNP	_	29	nn	_
29	afternoon	afternoon	NN	_	27	pobj	_
30	.	.	.	_	2	punct	_

1	In	in	IN	_	10	prep	10:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	to	to	IN	_	2	prep	_
4	the	the	DT	_	6	det	_
5	inadequate	inadequate	JJ	_	6	amod	_
6	price	price	NN	_	3	pobj	_
7	,	,	,	_	10	punct	_
8	Johansson	johansson	NNP	_	10	nsubj	10:A0=PAG
9	also	also	RB	_	10	advmod	10:AM-DIS
10	slammed	slam	VBD	pb=slam.02	0	root	_
11	what	what	WP	_	13	dobj	13:R-A1
12	he	he	PRP	_	13	nsubj	13:A0
13	said	say	VBD	pb=say.01	14	csubj	14:A1=PPT
14	was	be	VBD	pb=be.01	10	ccomp	10:A1=PPT
15	a	a	DT	_	16	det	_
16	lack	lack	NN	_	14	attr	14:A2=PRD
17	of	of	IN	_	16	prep	_
18	industrial	industrial	JJ	_	19	amod	_
19	logic	logic	NN	_	17	pobj	_
20	behind	behind	IN	_	19	prep	_
21	Pfizer	pfizer	NNP	p2=NN	23	poss	_
22	's	's	POS	_	21	possessive	_
23	move	move	NN	_	20	pobj	_
24	;	;	:	p2=,	10	punct	_
25	the	the	DT	_	26	det	_
26	risks	risk	NNS	_	12	appos	27:A1=PPT
27	posed	pose	VBN	pb=pose.02	26	partmod	_
28	to	to	IN	_	27	prep	27:A2=GOL
29	shareholders	shareholder	NNS	_	28	pobj	_
30	by	by	IN	_	27	agent	27:A0=PAG
31	the	the	DT	_	34	det	_
32	controversial	controversial	JJ	_	34	amod	_
33	tax	tax	NN	_	34	nn	_
34	plans	plan	NNS	_	30	pobj	_
35	;	;	:	p2=,	26	punct	_
36	and	and	CC	_	26	cc	_
37	the	the	DT	_	38	det	_
38	threat	threat	NN	_	26	conj	_
39	to	to	IN	_	38	prep	_
40	life	life	NN	_	42	nn	_
41	science	science	NN	_	42	nn	_
42	jobs	job	NNS	_	39	pobj	_
43	in	in	IN	_	42	prep	_
44	Britain	britain	NNP	_	43	pobj	_
45	,	,	,	_	44	punct	_
46	Sweden	sweden	NNP	_	44	conj	_
47	and	and	CC	_	46	cc	_
48	the	the	DT	_	50	det	_
49	United	united	NNP	_	50	nn	_
50	States	states	NNP	_	46	conj	_
51	.	.	.	_	10	punct	_

1	"	"	``	_	10	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	approach	approach	NN	_	10	nsubj	15:A1=PPT
5	throughout	throughout	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	pursuit	pursuit	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	appears	appear	VBZ	pb=appear.02	33	ccomp	33:A1=PPT
11	to	to	TO	_	15	aux	_
12	have	have	VB	_	15	aux	_
13	been	be	VBN	_	15	auxpass	_
14	fundamentally	fundamentally	RB	_	15	advmod	15:AM-MNR
15	driven	drive	VBN	pb=drive.02	10	xcomp	10:C-A1
16	by	by	IN	_	15	agent	15:A0=PAG
17	the	the	DT	_	20	det	_
18	corporate	corporate	JJ	_	20	amod	_
19	financial	financial	JJ	_	20	amod	_
20	benefits	benefit	NNS	_	16	pobj	_
21	to	to	IN	_	20	prep	_
22	its	its	PRP$	_	23	poss	_
23	shareholders	shareholder	NNS	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	cost	cost	NN	p2=JJ	26	nn	_
26	savings	saving	NNS	_	24	pobj	_
27	and	and	CC	_	26	cc	_
28	tax	tax	NN	_	29	nn	_
29	minimisation	minimisation	NN	_	26	conj	_
30	,	,	,	_	33	punct	_
31	"	"	''	p2=``	33	punct	_
32	Johansson	johansson	NNP	_	33	nsubj	33:A0
33	said	say	VBD	pb=say.01	0	root	_
34	in	in	IN	_	33	prep	33:AM-LOC
35	a	a	DT	_	36	det	_
36	statement	statement	NN	_	34	pobj	_
37	.	.	.	_	33	punct	_

1	"	"	``	p2=''	25	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	0	root	_
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	.	.	.	_	25	punct	_
37	"	"	''	_	25	punct	_

1	But	but	CC	_	7	cc	7:AM-DIS
2	many	many	JJ	_	7	nsubj	7:A1=PPT
3	of	of	IN	_	2	prep	_
4	Johansson	johansson	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	shareholders	shareholder	NNS	_	3	pobj	_
7	were	be	VBD	pb=be.01	0	root	_
8	deeply	deeply	RB	_	9	advmod	_
9	unimpressed	unimpressed	JJ	p2=VBN	7	acomp	7:A2=PRD
10	.	.	.	_	7	punct	_

1	"	"	``	_	5	punct	_
2	We	we	PRP	_	5	nsubj	5:A0
3	do	do	VBP	_	5	aux	_
4	not	not	RB	_	5	neg	5:AM-NEG
5	think	think	VB	pb=think.01	20	ccomp	20:A1=PPT
6	the	the	DT	_	8	det	_
7	Astra	astra	NNP	p2=NN	8	nn	_
8	management	management	NN	_	10	nsubj	10:A0=PAG
9	have	have	VBP	p2=VB	10	aux	_
10	done	do	VBN	pb=do.02	5	ccomp	5:A1=PPT
11	a	a	DT	_	13	det	_
12	good	good	JJ	_	13	amod	_
13	job	job	NN	_	10	dobj	10:A1=PPT
14	on	on	IN	_	13	prep	_
15	behalf	behalf	NN	_	14	pobj	_
16	of	of	IN	_	15	prep	_
17	shareholders	shareholder	NNS	_	16	pobj	_
18	,	,	,	_	20	punct	_
19	"	"	''	_	20	punct	_
20	said	say	VBD	pb=say.01	0	root	_
21	one	#crd#	CD	_	23	num	_
22	fund	fund	NN	_	23	nn	_
23	manager	manager	NN	_	20	nsubj	20:A0
24	at	at	IN	_	23	prep	_
25	a	a	DT	_	29	det	_
26	top	top	JJ	p2=RB	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	10	0	CD	p2=NN	29	nn	_
29	investor	investor	NN	_	24	pobj	_
30	in	in	IN	_	29	prep	_
31	the	the	DT	_	32	det	_
32	group	group	NN	_	30	pobj	_
33	.	.	.	_	20	punct	_

1	Alastair	alastair	NNP	p2=JJ	2	nn	_
2	Gunn	gunn	NNP	_	11	nsubj	11:A0
3	of	of	IN	_	2	prep	_
4	top	top	JJ	p2=RB	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	30	0	CD	p2=NN	10	nn	_
7	shareholder	shareholder	NN	_	9	nn	_
8	Jupiter	jupiter	NNP	_	9	nn	_
9	Fund	fund	NNP	_	10	nn	_
10	Management	management	NNP	_	3	pobj	_
11	said	say	VBD	pb=say.01	0	root	_
12	:	:	:	_	11	punct	_
13	"	"	``	_	11	punct	_
14	We	we	PRP	_	15	nsubj	15:A1=PPT;16:A1=PPT
15	are	be	VBP	pb=be.01	22	ccomp	_
16	disappointed	disappoint	VBN	p2=VBG|pb=disappoint.01	15	acomp	15:A2=PRD
17	the	the	DT	_	18	det	_
18	board	board	NN	_	22	nsubj	22:A0=PAG
19	of	of	IN	_	18	prep	_
20	AstraZeneca	astrazeneca	NNP	_	19	pobj	_
21	has	have	VBZ	_	22	aux	_
22	rejected	reject	VBN	pb=reject.01	11	ccomp	11:A1=PPT
23	Pfizer	pfizer	NNP	p2=NN	26	poss	_
24	's	's	POS	_	23	possessive	_
25	latest	late	JJS	_	26	amod	_
26	offer	offer	NN	p2=VBP	22	dobj	22:A1=PPT
27	so	so	RB	_	28	advmod	_
28	categorically	categorically	RB	_	22	advmod	22:AM-TMP
29	.	.	.	_	15	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG;6:A0=PAG
2	should	should	MD	_	3	aux	3:AM-MOD
3	have	have	VB	pb=have.03	0	root	_
4	at	at	RB	p2=IN	5	advmod	_
5	least	least	RBS	_	6	advmod	6:AM-ADV
6	engaged	engage	VBN	p2=JJ|pb=engage.01	3	xcomp	_
7	in	in	IN	_	6	prep	6:A2=PPT
8	a	a	DT	_	10	det	_
9	constructive	constructive	JJ	_	10	amod	_
10	conversation	conversation	NN	_	7	pobj	_
11	with	with	IN	_	10	prep	_
12	Pfizer	pfizer	NNP	p2=NN	11	pobj	_
13	.	.	.	_	3	punct	_
14	"	"	''	_	3	punct	_

1	However	however	RB	_	23	advmod	23:AM-DIS
2	,	,	,	_	23	punct	_
3	Pfizer	pfizer	NNP	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	proposed	propose	VBN	p2=JJ|pb=propose.01	6	amod	_
6	takeover	takeover	NN	_	23	nsubjpass	5:A1=PPT;10:A1=PPT;23:A1=PPT
7	,	,	,	_	6	punct	_
8	which	which	WDT	_	10	nsubj	10:R-A1
9	would	would	MD	_	10	aux	10:AM-MOD
10	be	be	VB	pb=be.01	6	rcmod	_
11	the	the	DT	_	16	det	_
12	largest	large	JJS	p2=RBS	14	hmod	_
13	-	-	HYPH	p2=,	14	hyph	_
14	ever	ever	RB	_	16	amod	_
15	foreign	foreign	JJ	_	16	amod	_
16	acquisition	acquisition	NN	_	10	attr	10:A2=PRD
17	of	of	IN	_	16	prep	_
18	a	a	DT	_	20	det	_
19	British	british	JJ	_	20	amod	_
20	company	company	NN	_	17	pobj	_
21	,	,	,	_	23	punct	_
22	is	be	VBZ	_	23	auxpass	_
23	opposed	oppose	VBN	pb=oppose.01	0	root	_
24	by	by	IN	_	23	agent	23:A0=PPT
25	many	many	JJ	_	26	amod	_
26	scientists	scientist	NNS	_	24	pobj	30:A0=PPT
27	and	and	CC	_	26	cc	_
28	politicians	politician	NNS	_	26	conj	_
29	who	who	WP	p2=TO	30	nsubj	30:R-A0
30	fear	fear	VBP	pb=fear.01	26	rcmod	_
31	it	it	PRP	_	33	nsubj	33:A0=PAG
32	would	would	MD	_	33	aux	33:AM-MOD
33	undermine	undermine	VB	pb=undermine.01	30	ccomp	30:A1=PAG
34	Britain	britain	NNP	_	37	poss	_
35	's	's	POS	_	34	possessive	_
36	science	science	NN	_	37	nn	_
37	base	base	NN	_	33	dobj	33:A1=PPT
38	.	.	.	_	23	punct	_

1	The	the	DT	_	3	det	_
2	U.S.	u.s.	NNP	_	3	nn	_
3	group	group	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	its	its	PRP$	_	7	poss	_
6	new	new	JJ	_	7	amod	_
7	offer	offer	NN	_	8	nsubj	8:A1=PPT;14:A1=PPT
8	was	be	VBD	pb=be.01	4	ccomp	4:A1=PPT
9	final	final	JJ	_	8	acomp	8:A2=PRD
10	and	and	CC	_	8	cc	_
11	could	could	MD	_	14	aux	14:AM-MOD
12	not	not	RB	_	14	neg	14:AM-NEG
13	be	be	VB	_	14	auxpass	_
14	increased	increase	VBN	pb=increase.01	8	conj	_
15	.	.	.	_	4	punct	_

1	It	it	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	6	nsubj	6:A0=PAG;17:A0=PAG
4	would	would	MD	_	6	aux	6:AM-MOD
5	not	not	RB	_	6	neg	6:AM-NEG
6	make	make	VB	pb=make.05	2	ccomp	2:A1=PPT
7	a	a	DT	_	9	det	_
8	hostile	hostile	JJ	_	9	amod	_
9	offer	offer	NN	_	6	dobj	6:AM-PRR
10	directly	directly	RB	_	6	advmod	6:AM-MNR
11	to	to	IN	p2=TO	6	prep	6:A2=DIR
12	AstraZeneca	astrazeneca	NNP	_	13	nn	_
13	shareholders	shareholder	NNS	_	11	pobj	_
14	and	and	CC	_	6	cc	_
15	would	would	MD	_	17	aux	17:AM-MOD
16	only	only	RB	_	17	advmod	17:AM-ADV
17	proceed	proceed	VB	pb=proceed.01	6	conj	_
18	with	with	IN	_	17	prep	17:A1=PPT
19	an	an	DT	_	20	det	_
20	offer	offer	NN	_	18	pobj	_
21	with	with	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	recommendation	recommendation	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	AstraZeneca	astrazeneca	NNP	_	27	nn	_
27	board	board	NN	_	24	pobj	_
28	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0=PAG
2	had	have	VBD	_	4	aux	_
3	also	also	RB	_	4	advmod	4:AM-DIS
4	increased	increase	VBN	p2=VBD|pb=increase.01	0	root	_
5	the	the	DT	_	7	det	_
6	cash	cash	NN	_	7	nn	_
7	element	element	NN	_	4	dobj	4:A1=PPT
8	in	in	IN	_	7	prep	_
9	its	its	PRP$	_	10	poss	_
10	offer	offer	NN	_	8	pobj	_
11	to	to	IN	_	4	prep	4:A4=GOL
12	45	0	CD	_	13	num	_
13	percent	percent	NN	_	11	pobj	_
14	,	,	,	_	4	punct	_
15	under	under	IN	_	20	prep	20:R-AM-LOC
16	which	which	WDT	_	15	pobj	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	shareholders	shareholder	NNS	_	20	nsubj	20:A0=PAG
19	would	would	MD	_	20	aux	20:AM-MOD
20	get	get	VB	pb=get.01	4	advcl	_
21	1.747	0	CD	_	22	num	_
22	shares	share	NNS	_	20	dobj	20:A1=PPT
23	in	in	IN	_	20	prep	_
24	the	the	DT	_	26	det	_
25	enlarged	enlarged	JJ	p2=VBN	26	amod	_
26	company	company	NN	_	23	pobj	_
27	for	for	IN	_	26	prep	_
28	each	each	DT	_	27	pobj	_
29	of	of	IN	_	28	prep	_
30	their	their	PRP$	_	32	poss	_
31	AstraZeneca	astrazeneca	NNP	p2=JJ	32	nn	_
32	shares	share	NNS	_	29	pobj	_
33	and	and	CC	_	20	cc	_
34	24.76	0	CD	_	35	num	_
35	pounds	pound	NNS	_	20	conj	_
36	in	in	IN	_	35	prep	_
37	cash	cash	NN	_	36	pobj	_
38	.	.	.	_	4	punct	_

1	The	the	DT	_	3	det	_
2	new	new	JJ	_	3	amod	_
3	offer	offer	NN	_	4	nsubj	4:A0=PAG
4	represents	represent	VBZ	pb=represent.01	0	root	_
5	a	a	DT	_	9	det	_
6	15	0	CD	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	percent	percent	NN	_	9	nn	_
9	premium	premium	NN	_	4	dobj	4:A1=PPT
10	over	over	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	current	current	JJ	_	13	amod	_
13	value	value	NN	_	10	pobj	_
14	of	of	IN	_	13	prep	_
15	a	a	DT	_	21	det	_
16	cash	cash	NN	_	21	nn	_
17	-	-	HYPH	_	16	hyph	_
18	and	and	CC	_	16	cc	_
19	-	-	HYPH	_	20	hyph	_
20	share	share	NN	p2=VB	16	conj	_
21	approach	approach	NN	_	14	pobj	22:A1=PPT
22	made	make	VBN	p2=VBD|pb=make.05	21	partmod	_
23	on	on	IN	_	22	prep	22:AM-TMP
24	May	may	NNP	_	23	pobj	_
25	2	0	CD	_	27	hmod	_
26	-	-	HYPH	p2=:	27	hyph	_
27	worth	worth	JJ	p2=NN	24	num	_
28	50	0	CD	_	29	num	_
29	pounds	pound	NNS	p2=VBZ	4	dobj	_
30	a	a	DT	_	31	det	_
31	share	share	NN	_	29	npadvmod	_
32	at	at	IN	_	31	prep	_
33	the	the	DT	_	34	det	_
34	time	time	NN	_	32	pobj	40:AM-TMP
35	-	-	,	p2=:	34	punct	_
36	which	which	WDT	_	40	nsubjpass	40:R-A1
37	was	be	VBD	_	40	auxpass	_
38	also	also	RB	_	40	advmod	40:AM-ADV
39	swiftly	swiftly	RB	_	40	advmod	40:AM-MNR
40	rejected	reject	VBN	pb=reject.01	34	rcmod	_
41	by	by	IN	_	40	agent	40:A0=PAG
42	AstraZeneca	astrazeneca	NNP	_	41	pobj	_
43	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	poss	_
2	's	's	POS	p2=VBZ	1	possessive	_
3	Read	read	NNP	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	he	he	PRP	_	6	nsubj	6:A0=PAG
6	believed	believe	VBD	pb=believe.01	4	ccomp	4:A1=PPT
7	his	his	PRP$	_	8	poss	_
8	proposal	proposal	NN	_	9	nsubj	17:A0=PAG;9:A1=PPT
9	was	be	VBD	pb=be.01	6	ccomp	6:A1=PPT
10	"	"	``	_	11	punct	_
11	compelling	compelling	JJ	p2=VBG	9	acomp	9:A2=PRD
12	"	"	''	_	11	punct	_
13	for	for	IN	_	11	prep	_
14	AstraZeneca	astrazeneca	NNP	_	15	nn	_
15	shareholders	shareholder	NNS	_	13	pobj	_
16	and	and	CC	_	9	cc	_
17	expressed	express	VBD	pb=express.01	9	conj	_
18	frustration	frustration	NN	_	17	dobj	17:A1=PPT
19	at	at	IN	_	18	prep	_
20	its	its	PRP$	_	21	poss	_
21	refusal	refusal	NN	_	19	pobj	_
22	to	to	TO	_	23	aux	_
23	talk	talk	VB	pb=talk.01	21	infmod	_
24	,	,	,	_	17	punct	_
25	urging	urge	VBG	pb=urge.01	17	advcl	17:AM-ADV
26	the	the	DT	_	28	det	_
27	British	british	JJ	_	28	amod	_
28	company	company	NN	_	30	poss	_
29	's	's	POS	_	28	possessive	_
30	shareholders	shareholder	NNS	_	25	dobj	32:A0=PAG;25:A1=PPT
31	to	to	TO	_	32	aux	_
32	pressure	pressure	VB	pb=pressure.01	25	xcomp	25:A2=PPT
33	its	its	PRP$	_	34	poss	_
34	board	board	NN	_	32	dobj	36:A0=PAG;32:A1=PPT
35	to	to	TO	_	36	aux	_
36	engage	engage	VB	pb=engage.01	32	xcomp	32:A2=PRD
37	.	.	.	_	4	punct	_

1	In	in	IN	_	27	prep	27:AM-LOC
2	the	the	DT	_	3	det	_
3	absence	absence	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	further	far	JJ	_	6	amod	_
6	discussions	discussion	NNS	_	4	pobj	_
7	or	or	CC	_	6	cc	_
8	an	an	DT	_	9	det	_
9	extension	extension	NN	_	6	conj	_
10	of	of	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	deadline	deadline	NN	_	10	pobj	_
13	for	for	IN	_	12	prep	_
14	making	make	VBG	pb=make.LV	13	pcomp	_
15	a	a	DT	_	17	det	_
16	firm	firm	JJ	p2=NN	17	amod	_
17	offer	offer	NN	_	14	dobj	14:AM-PRR
18	under	under	IN	_	17	prep	_
19	British	british	JJ	_	21	amod	_
20	takeover	takeover	NN	_	21	nn	_
21	rules	rule	NNS	_	18	pobj	_
22	,	,	,	_	27	punct	_
23	Pfizer	pfizer	NNP	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	proposal	proposal	NN	_	27	nsubj	27:A1=PPT
26	will	will	MD	_	27	aux	27:AM-MOD
27	expire	expire	VB	pb=expire.01	0	root	_
28	at	at	IN	_	27	prep	27:AM-TMP
29	5	0	CD	_	30	num	_
30	p.m.	p.m.	NN	p2=RB	28	pobj	_
31	(	(	-LRB-	_	30	punct	_
32	1700	0	CD	_	33	num	_
33	BST	bst	NN	p2=NNP	30	appos	_
34	)	)	-RRB-	_	30	punct	_
35	on	on	IN	_	27	prep	27:AM-TMP
36	May	may	NNP	_	35	pobj	_
37	26	0	CD	_	36	num	_
38	.	.	.	_	27	punct	_

1	After	after	IN	_	6	prep	6:AM-TMP
2	that	that	DT	_	1	pobj	_
3	,	,	,	_	6	punct	_
4	it	it	PRP	_	6	nsubj	8:A1=PPT
5	would	would	MD	_	6	aux	_
6	have	have	VB	pb=have.02	0	root	_
7	to	to	TO	_	8	aux	_
8	wait	wait	VB	pb=wait.01	6	xcomp	_
9	six	#crd#	CD	_	10	num	_
10	months	month	NNS	_	8	npadvmod	8:AM-TMP
11	before	before	IN	_	8	prep	8:AM-TMP
12	making	make	VBG	pb=make.01	11	pcomp	_
13	another	another	DT	_	14	det	_
14	bid	bid	NN	_	12	dobj	12:AM-PRR
15	.	.	.	_	6	punct	_

1	"	"	``	_	4	punct	_
2	AstraZeneca	astrazeneca	NNP	_	4	nsubj	4:A0=PAG
3	will	will	MD	_	4	aux	4:AM-MOD
4	have	have	VB	pb=have.03	29	ccomp	29:A1=PPT
5	six	#crd#	CD	_	6	num	_
6	months	month	NNS	_	4	dobj	4:A1=PPT
7	to	to	TO	_	8	aux	_
8	demonstrate	demonstrate	VB	pb=demonstrate.01	6	infmod	_
9	that	that	IN	_	11	complm	_
10	it	it	PRP	_	11	nsubj	_
11	was	be	VBD	pb=be.01	8	ccomp	8:A1=PPT
12	right	right	JJ	p2=RB	11	acomp	11:A2=PRD
13	to	to	TO	p2=IN	14	aux	_
14	reject	reject	VB	pb=reject.01	11	xcomp	11:A1=PPT
15	Pfizer	pfizer	NNP	_	17	poss	_
16	's	's	POS	_	15	possessive	_
17	offer	offer	NN	_	14	dobj	14:A1=PPT
18	,	,	,	_	17	punct	_
19	or	or	CC	_	14	cc	_
20	face	face	VB	p2=VBP|pb=face.01	14	conj	_
21	the	the	DT	_	22	det	_
22	prospect	prospect	NN	_	20	dobj	20:A1
23	of	of	IN	_	22	prep	_
24	a	a	DT	_	26	det	_
25	fresh	fresh	JJ	_	26	amod	_
26	approach	approach	NN	_	23	pobj	_
27	,	,	,	_	29	punct	_
28	"	"	''	_	29	punct	_
29	said	say	VBD	pb=say.01	0	root	_
30	analyst	analyst	NN	_	32	nn	_
31	Mick	mick	NNP	_	32	nn	_
32	Cooper	cooper	NNP	_	29	nsubj	29:A0
33	at	at	IN	_	32	prep	_
34	Edison	edison	NNP	_	36	nn	_
35	Investment	investment	NNP	_	36	nn	_
36	Research	research	NNP	_	33	pobj	_
37	.	.	.	_	29	punct	_

1	While	while	IN	_	4	mark	_
2	Pfizer	pfizer	NNP	_	4	nsubj	6:A1=PPT
3	would	would	MD	_	4	aux	_
4	have	have	VB	pb=have.02	15	advcl	15:AM-ADV
5	to	to	TO	_	6	aux	_
6	wait	wait	VB	pb=wait.01	4	xcomp	_
7	on	on	IN	_	6	prep	6:AM-LOC
8	the	the	DT	_	9	det	_
9	sidelines	sideline	NNS	_	7	pobj	_
10	until	until	IN	_	6	prep	6:AM-TMP
11	November	november	NNP	_	10	pobj	_
12	,	,	,	_	15	punct	_
13	it	it	PRP	_	15	nsubj	_
14	would	would	MD	_	15	aux	15:AM-MOD
15	be	be	VB	pb=be.01	0	root	_
16	possible	possible	JJ	_	15	acomp	15:A2=PRD
17	for	for	IN	_	20	mark	_
18	AstraZeneca	astrazeneca	NNP	p2=NNS	20	nsubj	20:A0=PAG
19	to	to	TO	_	20	aux	_
20	initiate	initiate	VB	pb=initiate.01	15	advcl	15:A1=PPT
21	talks	talk	NNS	_	20	dobj	20:A1=PPT
22	from	from	IN	_	20	prep	_
23	late	late	JJ	_	24	amod	_
24	August	august	NNP	_	22	pobj	_
25	,	,	,	_	20	punct	_
26	if	if	IN	_	28	mark	_
27	it	it	PRP	_	28	nsubj	28:A0=PAG
28	decided	decide	VBD	pb=decide.01	20	advcl	20:AM-ADV
29	it	it	PRP	_	30	nsubj	30:A0=PAG;31:A0=PAG
30	wants	want	VBZ	pb=want.01	28	ccomp	28:A1=PPT
31	coax	coax	VB	p2=IN|pb=coax.01	30	xcomp	30:A1=PPT
32	a	a	DT	_	34	det	_
33	higher	high	JJR	_	34	amod	_
34	offer	offer	NN	_	31	dobj	31:A1=PPT
35	.	.	.	_	15	punct	_

1	The	the	DT	_	4	det	_
2	latest	late	JJS	p2=RBS	4	amod	_
3	increased	increase	VBN	p2=VBD|pb=increase.01	4	amod	_
4	offer	offer	NN	_	8	nsubjpass	3:A1=PPT;8:A1=PPT
5	had	have	VBD	p2=VBN	8	aux	_
6	been	be	VBN	_	8	auxpass	_
7	widely	widely	RB	_	8	advmod	8:AM-MNR
8	expected	expect	VBN	pb=expect.01	0	root	_
9	.	.	.	_	8	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	last	last	JJ	_	4	amod	_
4	week	week	NN	_	2	npadvmod	2:AM-TMP
5	it	it	PRP	_	7	nsubj	7:A0=PAG
6	would	would	MD	_	7	aux	7:AM-MOD
7	consider	consider	VB	pb=consider.01	2	ccomp	2:A1=PPT
8	a	a	DT	_	10	det	_
9	higher	high	JJR	_	10	amod	_
10	offer	offer	NN	_	7	dobj	7:A1
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A0=PAG
13	urged	urge	VBD	pb=urge.01	7	advcl	7:AM-TMP
14	AstraZeneca	astrazeneca	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	board	board	NN	_	13	dobj	18:A0=PPT;13:A1=PPT
17	to	to	TO	_	18	aux	_
18	enter	enter	VB	pb=enter.01	13	xcomp	13:A2=PPT
19	talks	talk	NNS	_	18	dobj	18:A1=LOC
20	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	British	british	JJ	_	3	amod	_
3	firm	firm	NN	_	5	nsubj	5:A0=PAG;15:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	laid	lay	VBN	pb=lay.01	0	root	_
6	out	out	RP	_	5	prt	5:C-V
7	details	detail	NNS	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	its	its	PRP$	_	10	poss	_
10	pipeline	pipeline	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	new	new	JJ	_	13	amod	_
13	drugs	drug	NNS	_	11	pobj	_
14	and	and	CC	_	5	cc	_
15	argues	argue	VBZ	p2=NNS|pb=argue.01	5	conj	_
16	it	it	PRP	_	17	nsubj	17:A0=PAG
17	has	have	VBZ	p2=VBP|pb=have.03	15	ccomp	15:A1=PPT
18	no	no	DT	_	19	det	_
19	need	need	NN	_	17	dobj	17:A1=PPT
20	for	for	IN	_	19	prep	_
21	a	a	DT	_	22	det	_
22	deal	deal	NN	_	20	pobj	_
23	.	.	.	_	5	punct	_

1	However	however	RB	_	5	advmod	5:AM-DIS
2	,	,	,	_	5	punct	_
3	many	many	JJ	_	4	amod	_
4	analysts	analyst	NNS	_	5	nsubj	5:A0=PAG
5	believe	believe	VBP	pb=believe.01	0	root	_
6	its	its	PRP$	_	7	poss	_
7	projections	projection	NNS	_	24	nsubj	24:A1=PPT
8	that	that	IN	_	11	complm	_
9	it	it	PRP	_	11	nsubj	11:A0=PAG
10	can	can	MD	_	11	aux	11:AM-MOD
11	increase	increase	VB	pb=increase.01	7	ccomp	_
12	sales	sale	NNS	_	11	dobj	11:A1=PPT
13	by	by	IN	_	11	prep	11:AM-MNR
14	75	0	CD	_	15	num	_
15	percent	percent	NN	_	13	pobj	_
16	to	to	IN	_	11	prep	11:A4=GOL
17	$	$	$	_	19	quantmod	_
18	45	0	CD	_	19	number	_
19	billion	#crd#	CD	_	16	pobj	_
20	a	a	DT	_	21	det	_
21	year	year	NN	_	19	npadvmod	_
22	by	by	IN	_	19	prep	_
23	2023	0	CD	_	22	pobj	_
24	are	be	VBP	pb=be.01	5	ccomp	5:A1=PPT
25	over-optimistic	over-optimistic	JJ	_	24	acomp	24:A2=PRD
26	.	.	.	_	5	punct	_

1	There	there	EX	_	3	expl	_
2	has	have	VBZ	_	3	aux	_
3	been	be	VBN	pb=be.02	0	root	_
4	a	a	DT	_	7	det	_
5	mounting	mount	VBG	p2=JJ|pb=mount.02	7	amod	_
6	political	political	JJ	_	7	amod	_
7	backlash	backlash	NN	_	3	attr	3:A1=PPT;5:A1=PPT
8	against	against	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	proposed	propose	VBN	p2=JJ|pb=propose.01	11	amod	_
11	deal	deal	NN	_	8	pobj	10:A1=PPT
12	in	in	IN	_	11	prep	_
13	Britain	britain	NNP	_	12	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	17	det	_
16	United	united	NNP	_	17	nn	_
17	States	states	NNP	_	13	conj	_
18	and	and	CC	_	17	cc	_
19	Sweden	sweden	NNP	_	17	conj	_
20	,	,	,	_	17	punct	_
21	where	where	WRB	_	23	advmod	23:R-AM-LOC
22	AstraZeneca	astrazeneca	NNP	_	23	nsubj	23:A0=PAG
23	has	have	VBZ	pb=have.03	17	rcmod	_
24	half	half	PDT	p2=VBN	26	predet	_
25	its	its	PRP$	_	26	poss	_
26	roots	root	NNS	_	23	dobj	23:A1=PPT
27	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	Swedish	swedish	JJ	_	3	amod	_
3	government	government	NN	_	4	nsubj	4:A0=PAG
4	launched	launch	VBD	pb=launch.01	0	root	_
5	a	a	DT	_	7	det	_
6	concerted	concerted	JJ	_	7	amod	_
7	effort	effort	NN	_	4	dobj	4:A1=PPT
8	on	on	IN	_	4	prep	4:AM-TMP
9	Friday	friday	NNP	_	8	pobj	_
10	against	against	IN	_	4	prep	_
11	a	a	DT	_	12	det	_
12	merger	merger	NN	_	10	pobj	_
13	that	that	WDT	p2=IN	17	nsubj	17:R-A0
14	it	it	PRP	_	15	nsubj	15:A0=PPT
15	fears	fear	VBZ	pb=fear.01	12	rcmod	_
16	will	will	MD	_	17	aux	17:AM-MOD
17	lead	lead	VB	pb=lead.03	15	ccomp	15:A1=PAG
18	to	to	IN	_	17	prep	17:A2=PRD
19	cuts	cut	NNS	_	18	pobj	_
20	in	in	IN	_	19	prep	_
21	science	science	NN	_	22	nn	_
22	jobs	job	NNS	_	20	pobj	_
23	and	and	CC	_	22	cc	_
24	research	research	NN	_	22	conj	_
25	,	,	,	_	19	punct	_
26	echoing	echo	VBG	pb=echo.01	27	amod	_
27	concerns	concern	NNS	_	19	conj	26:A0=PPT;28:A1=PPT
28	aired	air	VBN	pb=air.01	27	partmod	_
29	by	by	IN	_	28	agent	28:A0=PAG
30	British	british	JJ	_	31	amod	_
31	lawmakers	lawmaker	NNS	_	29	pobj	_
32	at	at	IN	_	28	prep	28:AM-LOC
33	two	#crd#	CD	_	35	num	_
34	parliamentary	parliamentary	JJ	_	35	amod	_
35	hearings	hearing	NNS	_	32	pobj	_
36	last	last	JJ	p2=VBP	37	amod	_
37	week	week	NN	_	28	npadvmod	28:AM-TMP
38	,	,	,	_	27	punct	_
39	and	and	CC	_	27	cc	_
40	fears	fear	NNS	_	27	conj	_
41	for	for	IN	_	40	prep	_
42	U.S.	u.s.	NNP	_	43	nn	_
43	jobs	job	NNS	_	41	pobj	_
44	in	in	IN	_	43	prep	_
45	states	state	NNS	_	44	pobj	48:AM-LOC
46	where	where	WRB	_	48	advmod	48:R-AM-LOC
47	AstraZeneca	astrazeneca	NNP	_	48	nsubj	48:A0=PAG
48	has	have	VBZ	pb=have.03	45	rcmod	_
49	a	a	DT	_	51	det	_
50	large	large	JJ	_	51	amod	_
51	presence	presence	NN	_	48	dobj	48:A1=PPT
52	.	.	.	_	4	punct	_

1	British	british	JJ	_	3	amod	_
2	Prime	prime	NNP	_	3	nn	_
3	Minister	minister	NNP	_	5	nn	_
4	David	david	NNP	_	5	nn	_
5	Cameron	cameron	NNP	_	7	nsubj	7:A0
6	has	have	VBZ	_	7	aux	_
7	said	say	VBN	p2=VBD|pb=say.01	0	root	_
8	he	he	PRP	_	9	nsubj	9:A0=PAG
9	wanted	want	VBD	pb=want.01	7	ccomp	7:A1=PPT
10	more	more	JJR	_	11	amod	_
11	assurances	assurance	NNS	_	9	dobj	9:A1=PPT
12	from	from	IN	_	11	prep	_
13	Pfizer	pfizer	NNP	_	12	pobj	_
14	,	,	,	_	9	punct	_
15	in	in	IN	_	9	prep	_
16	the	the	DT	_	17	det	_
17	event	event	NN	_	15	pobj	_
18	of	of	IN	_	17	prep	_
19	a	a	DT	_	20	det	_
20	takeover	takeover	NN	_	18	pobj	_
21	,	,	,	_	15	punct	_
22	although	although	IN	_	36	mark	_
23	as	as	IN	_	36	prep	_
24	the	the	DT	_	25	det	_
25	head	head	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	the	the	DT	_	32	det	_
28	free	free	JJ	_	30	hmod	_
29	-	-	HYPH	_	30	hyph	_
30	market	market	NN	_	32	nn	_
31	Conservative	conservative	NNP	p2=JJ	32	nn	_
32	Party	party	NNP	_	26	pobj	_
33	he	he	PRP	_	36	nsubj	36:A0=PAG;42:A0=PAG;39:A1
34	does	do	VBZ	_	36	aux	_
35	not	not	RB	_	36	neg	36:AM-NEG
36	want	want	VB	pb=want.01	11	advcl	_
37	to	to	TO	_	39	aux	_
38	be	be	VB	_	39	auxpass	_
39	seen	see	VBN	pb=see.01	36	xcomp	36:A1=PPT
40	to	to	TO	_	42	aux	_
41	be	be	VB	_	42	aux	_
42	deterring	deter	VBG	pb=deter.01	39	xcomp	39:C-A1
43	foreign	foreign	JJ	_	45	amod	_
44	corporate	corporate	JJ	_	45	amod	_
45	investment	investment	NN	_	42	dobj	42:A1=PAG
46	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	_	2	nsubj	2:A0=PAG;36:A0=PAG
2	gave	give	VBD	pb=give.01	0	root	_
3	a	a	DT	_	7	det	_
4	five	#crd#	CD	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	year	year	NN	_	7	nn	_
7	commitment	commitment	NN	_	2	dobj	2:A1=PPT
8	to	to	IN	p2=TO	7	prep	_
9	complete	complete	JJ	p2=VB	10	amod	_
10	AstraZeneca	astrazeneca	NNP	_	14	poss	_
11	's	's	POS	_	10	possessive	_
12	new	new	JJ	_	14	amod	_
13	research	research	NN	_	14	nn	_
14	centre	centre	NN	_	8	pobj	_
15	in	in	IN	_	14	prep	_
16	Cambridge	cambridge	NNP	_	15	pobj	_
17	,	,	,	_	18	punct	_
18	retain	retain	VB	p2=VBP|pb=retain.01	7	advcl	_
19	a	a	DT	_	20	det	_
20	factory	factory	NN	_	18	dobj	18:A1=PPT
21	in	in	IN	_	20	prep	_
22	northern	northern	JJ	_	23	amod	_
23	England	england	NNP	_	21	pobj	_
24	and	and	CC	_	18	cc	_
25	put	put	VB	p2=VBD|pb=put.01	18	conj	_
26	a	a	DT	_	27	det	_
27	fifth	#ord#	NN	p2=JJ	25	dobj	25:A1=PPT
28	of	of	IN	_	27	prep	_
29	its	its	PRP$	_	31	poss	_
30	research	research	NN	_	31	nn	_
31	staff	staff	NN	_	28	pobj	_
32	in	in	IN	_	25	prep	25:A2=GOL
33	Britain	britain	NNP	_	32	pobj	_
34	,	,	,	_	2	punct	_
35	but	but	CC	_	2	cc	_
36	added	add	VBD	pb=add.01	2	conj	_
37	that	that	IN	_	42	complm	_
38	these	these	DT	_	39	det	_
39	pledges	pledge	NNS	_	42	nsubjpass	42:A1=PPT
40	could	could	MD	_	42	aux	42:AM-MOD
41	be	be	VB	_	42	auxpass	_
42	adjusted	adjust	VBN	pb=adjust.01	36	ccomp	36:A1=PPT
43	if	if	IN	_	45	mark	_
44	circumstances	circumstance	NNS	_	45	nsubj	45:A1=PPT
45	changed	change	VBN	p2=VBD|pb=change.01	42	advcl	42:AM-ADV
46	"	"	``	p2=''	47	punct	_
47	significantly	significantly	RB	_	45	advmod	45:AM-MNR
48	"	"	''	_	36	punct	_
49	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	tax	tax	NN	_	3	nn	_
3	aspects	aspect	NNS	_	11	nsubj	11:A0=CAU
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	deal	deal	NN	_	4	pobj	_
7	,	,	,	_	11	punct	_
8	meanwhile	meanwhile	RB	_	11	advmod	11:AM-TMP
9	,	,	,	_	11	punct	_
10	have	have	VBP	_	11	aux	_
11	sparked	spark	VBN	pb=spark.01	0	root	_
12	anger	anger	NN	_	11	dobj	11:A1=PPT
13	in	in	IN	_	11	prep	_
14	the	the	DT	_	16	det	_
15	United	united	NNP	_	16	nn	_
16	States	states	NNP	_	13	pobj	_
17	,	,	,	_	16	punct	_
18	where	where	WRB	_	22	advmod	22:R-AM-LOC
19	lawmakers	lawmaker	NNS	_	22	nsubj	22:A0=PAG;25:A0=PAG
20	are	be	VBP	_	22	aux	_
21	now	now	RB	_	22	advmod	22:AM-TMP
22	considering	consider	VBG	pb=consider.02	16	rcmod	_
23	legislation	legislation	NN	_	22	dobj	22:A1=PPT;25:AM-MNR
24	to	to	TO	_	25	aux	_
25	prevent	prevent	VB	pb=prevent.01	23	infmod	_
26	what	what	WP	_	28	nsubjpass	28:R-A1
27	are	be	VBP	_	28	auxpass	_
28	known	know	VBN	pb=know.01	25	ccomp	25:A1=PPT
29	as	as	IN	_	28	prep	28:A2=PRD
30	corporate	corporate	JJ	_	31	amod	_
31	inversions	inversion	NNS	_	29	pobj	37:AM-LOC
32	,	,	,	_	31	punct	_
33	under	under	IN	_	37	prep	37:R-AM-LOC
34	which	which	WDT	_	33	pobj	_
35	U.S.	u.s.	NNP	_	36	nn	_
36	companies	company	NNS	_	37	nsubj	37:A0;40:A0=PAG
37	re-incorporate	re-incorporate	VBP	pb=re-incorporate.01	31	rcmod	_
38	overseas	overseas	JJ	p2=RB	37	advmod	37:A2
39	to	to	TO	_	40	aux	_
40	avoid	avoid	VB	pb=avoid.01	37	advcl	37:AM-PRP
41	U.S.	u.s.	NNP	_	42	nn	_
42	taxes	tax	NNS	_	40	dobj	40:A1=PPT
43	.	.	.	_	11	punct	_

1	Inversions	inversion	NNS	_	3	nsubj	3:A0=PAG;4:A2=PPT
2	have	have	VBP	_	3	aux	_
3	helped	help	VBN	p2=VBD|pb=help.01	0	root	_
4	fuel	fuel	VB	p2=NN|pb=fuel.01	3	xcomp	3:A1=PPT
5	a	a	DT	_	6	det	_
6	wave	wave	NN	_	4	dobj	4:A1=GOL
7	of	of	IN	_	6	prep	_
8	deals	deal	NNS	_	7	pobj	_
9	in	in	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	pharmaceuticals	pharmaceutical	NNS	_	12	nn	_
12	sector	sector	NN	_	9	pobj	_
13	in	in	IN	_	6	prep	_
14	recent	recent	JJ	_	15	amod	_
15	months	month	NNS	_	13	pobj	_
16	.	.	.	_	3	punct	_

1	Buying	buy	VBG	p2=NN|pb=buy.01	4	csubj	4:A0=PAG
2	AstraZeneca	astrazeneca	NNP	_	1	dobj	1:A1=PPT
3	would	would	MD	_	4	aux	4:AM-MOD
4	allow	allow	VB	pb=allow.01	0	root	_
5	Pfizer	pfizer	NNP	_	7	nsubj	7:A0=PAG
6	to	to	TO	_	7	aux	_
7	carry	carry	VB	pb=carry.03	4	ccomp	4:A1=PPT
8	out	out	RP	_	7	prt	7:C-V
9	the	the	DT	_	12	det	_
10	largest	large	JJS	_	12	amod	_
11	such	such	JJ	_	12	amod	_
12	deal	deal	NN	_	7	dobj	7:A1=PPT
13	yet	yet	RB	_	7	advmod	7:AM-TMP
14	.	.	.	_	4	punct	_

